Insider · CIK 0001433457

Thomsen Jillian B.

Reports to the SEC for 1 company · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001433457

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−10.3K sh	$3.00	−$30.8K	313,497
2022-11-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−11.1K sh	$3.57	−$39.6K	323,764
2022-08-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−2,006 sh	$4.76	−$9,548.56	334,859
2022-08-15	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+166K sh	—	—	336,865
2022-08-15	NKTRNEKTAR THERAPEUTICS · Common StockA Award	Chief Financial Officer	AAward	+332K sh	—	—	331,875
2022-05-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−5,841 sh	$3.95	−$23.1K	170,427
2022-05-15	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+11K sh	—	—	176,268
2022-02-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−2,363 sh	$10.95	−$25.9K	165,318
2021-12-16	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+21.2K sh	—	—	167,681
2021-12-16	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Financial Officer	AAward	+37.6K sh	—	—	37,600
2021-11-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−6,741 sh	$13.16	−$88.7K	145,981
2021-11-15	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+14.9K sh	—	—	152,722
2021-10-12	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Financial Officer	AAward	+26.6K sh	—	—	26,600
2021-08-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−13.3K sh	$13.83	−$184K	137,822
2021-05-17	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−13.4K sh	$18.30	−$245K	151,161
2021-02-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−11.7K sh	$22.37	−$262K	164,552
2021-01-28	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+37.5K sh	$8.80	+$330K	213,757
2021-01-28	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+37.5K sh	$8.80	+$330K	251,257
2021-01-28	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−75K sh	$18.62	−$1.4M	176,257
2021-01-28	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−37.5K sh	—	—	0
2021-01-28	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−37.5K sh	—	—	0
2020-12-18	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+16K sh	—	—	176,257
2020-12-18	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Financial Officer	AAward	+28.6K sh	—	—	28,600
2020-11-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−12K sh	$16.93	−$203K	159,757
2020-08-17	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−1,367 sh	$19.67	−$26.9K	171,733
2020-05-18	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−1,367 sh	$22.51	−$30.8K	172,719
2020-02-18	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−1,394 sh	$22.35	−$31.2K	174,086
2020-02-06	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+37.5K sh	$7.21	+$270K	212,980
2020-02-06	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−37.5K sh	$22.78	−$854K	175,480
2020-02-06	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−37.5K sh	—	—	0
2019-12-12	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+14.9K sh	—	—	175,480
2019-12-12	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Financial Officer	AAward	+26.6K sh	—	—	26,600
2019-12-12	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Financial Officer	AAward	+11.8K sh	—	—	11,800
2019-11-18	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−2,713 sh	$17.97	−$48.8K	160,441
2019-08-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−1,809 sh	$18.15	−$32.8K	163,154
2019-05-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−1,928 sh	$31.37	−$60.5K	164,463
2019-02-19	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−1,808 sh	$42.39	−$76.6K	166,391
2019-02-04	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+16.1K sh	$10.69	+$172K	184,318
2019-02-04	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−16.1K sh	$42.16	−$680K	168,199
2019-02-04	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−16.1K sh	—	—	0
2018-12-14	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+11K sh	—	—	168,199
2018-12-14	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Financial Officer	AAward	+22.2K sh	—	—	22,150
2018-11-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−4,016 sh	$38.25	−$154K	157,249
2018-11-01	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+90K sh	—	—	161,265
2018-08-16	NKTRNEKTAR THERAPEUTICSD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−4,883 sh	$58.40	−$285K	71,265
2018-08-15	NKTRNEKTAR THERAPEUTICSA Award	Chief Financial Officer	AAward	+10.4K sh	—	—	76,148
2018-08-15	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Financial Officer	AAward	+26.3K sh	—	—	26,250
2018-05-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−3,576 sh	$83.39	−$298K	65,281
2018-04-16	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+13.9K sh	$10.69	+$148K	82,738
2018-04-16	NKTRNEKTAR THERAPEUTICSS Sale	Chief Financial Officer	SSale	−13.9K sh	$101.46	−$1.41M	68,857

Recent filings

Accepted (ET)
Feb 174
Thomsen Jillian B.0001209191-23-010953
SEC(opens sec.gov)
Nov 184
Thomsen Jillian B.0001209191-22-057966
SEC(opens sec.gov)
Aug 174
Thomsen Jillian B.0001209191-22-046487
SEC(opens sec.gov)
May 174
Thomsen Jillian B.0001209191-22-029903
SEC(opens sec.gov)
Feb 184
Thomsen Jillian B.0001209191-22-011439
SEC(opens sec.gov)
Dec 204
Thomsen Jillian B.0001209191-21-070693
SEC(opens sec.gov)
Nov 174
Thomsen Jillian B.0001209191-21-065223
SEC(opens sec.gov)
Oct 144
Thomsen Jillian B.0001209191-21-060511
SEC(opens sec.gov)
Aug 184
Thomsen Jillian B.0001209191-21-052390
SEC(opens sec.gov)
May 194
Thomsen Jillian B.0001209191-21-034188
SEC(opens sec.gov)
Feb 184
Thomsen Jillian B.0001209191-21-012122
SEC(opens sec.gov)
Jan 294
Thomsen Jillian B.0001209191-21-006211
SEC(opens sec.gov)

Companies

NEKTAR THERAPEUTICSChief Financial OfficerNKTR

Address

C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD

SAN CARLOS, CA, 94070